Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $11
OptimizeRx Corp OPRX
$5.16
βΌ -0.39%
($-0.02)
Open
$5.14
Prev Close
$5.18
Day Range
$5.09 β $5.34
52W Range
$4.57 β $22.25
Market Cap
$97.58M
P/E (TTM)
18.94
Beta
1.12
EPS (TTM)
$0.27
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2005-05-18 |
| Shares Out. | 18,760,000 |
| Website | optimizerx.com/ β |
| Phone | 12486516558 |
OptimizeRx Corp is a publicly traded company under the ticker symbol OPRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
13 analysts (2026-05-01)
π° Latest News for OPRX
B. Riley Securities Maintains Buy on OptimizeRx, Lowers Price Target to $10
12 Health Care Stocks Moving In Wednesday's Intraday Session
Stephens & Co. Maintains Equal-Weight on OptimizeRx, Lowers Price Target to $7
Stifel Maintains Buy on OptimizeRx, Lowers Price Target to $14
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance
OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript
Optimizerx Corp enters credit agreement with Fifth Third Bank on May 7, 2026 - SEC filing
